Welcome to GENESIS Hangzhou!

page_banner

news

Genesis KaiBiLi COVID-19 antigen test kit(self-testing and professional version)  got Austria certification. Rapid COVID-19 Antigen test kit is a valuable weapon in the SARS-CoV-2 mutations continues their spread.

COVID-19 Antigen (Self-test) can qualitative test, performed and results can be obtained in 15 minutes. With regular testing at home, you and your family can know your status so you can take action to help stop the spread of COVID-19. 

It can be tested without instruments and can be used at home or for professional medical tests.

COVID-19

Since COVID-19 pandemic is a global crisis, tests with high sensitivity and specificity are crucial for the identification and management of COVID-19 patients. There is an urgent need for a low-cost rapid antigen COVID-19 test with a good diagnostic performance.

Ensuring accurate diagnosis is essential to limit the spread of SARS-CoV-2 and for the clinical management of COVID-19. Although real-time reverse transcription-polymerase chain reaction (RT- qPCR) is the current recommended laboratory method to diagnose SARS-CoV-2 acute infection, several factors such as the requirement of special equipment and skilled staff limit the use of these time-consuming molecular techniques.

Novel Coronavirus (SARS-Cov-2) Antigen Rapid Test Device is an in vitro diagnostic test for the qualitative detection of Nucleoprotein of Coronavirus Disease 2019 in the human nasal swab, using the rapid immunochromatographic method as an aid in the diagnosis of SARS-Cov-2 infections. The identification is based on the monoclonal antibodies specific for the novel coronavirus antigen. It will provide information for clinical doctors to prescribe correct medications.

The KaiBiLi COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography, which can quickly and easily qualitatively detect the 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.


Post time: Aug-31-2021